Productive R&D is the lifeblood of leading pharmaceutical and biotech companies, and with increased pressure to create meaningful new medicines, R&D effectiveness can always be improved.
In our recent webinar, John Rountree, Managing Partner at Novasecta, was joined by a panel of pharma company R&D Heads, who shared their experiences on how they have been successful in transforming the performance of their R&D organisations.
The panel – Claude Bertrand (Executive Vice President R&D & CSO at Servier), Johan Luthman (Executive Vice President R&D at Lundbeck) and Dhaval Patel (Executive Vice President & CSO at UCB) discussed:
- The reasons for transforming R&D.
- The changes that have the most impact.
- How transformation is motivated and sustained.
If you are a Head of R&D, in an R&D Leadership position, or a CEO or COO in an innovative pharma or biotech company, you will definitely want to watch this on-demand webinar.
Click here to watch now.
